302 related articles for article (PubMed ID: 12927007)
1. A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
Hong CJ; Hu WH; Chen CC; Hsiao CC; Tsai SJ; Ruwe FJ
J Clin Psychiatry; 2003 Aug; 64(8):921-6. PubMed ID: 12927007
[TBL] [Abstract][Full Text] [Related]
2. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
Wheatley DP; van Moffaert M; Timmerman L; Kremer CM
J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
[TBL] [Abstract][Full Text] [Related]
3. Mirtazapine compared with paroxetine in major depression.
Benkert O; Szegedi A; Kohnen R
J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
5. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
Guelfi JD; Ansseau M; Timmerman L; Kørsgaard S;
J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
[TBL] [Abstract][Full Text] [Related]
7. Mirtazapine versus selective serotonin reuptake inhibitors.
Thompson C
J Clin Psychiatry; 1999; 60 Suppl 17():18-22; discussion 46-8. PubMed ID: 10446737
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
Fava M; Dunner DL; Greist JH; Preskorn SH; Trivedi MH; Zajecka J; Cohen M
J Clin Psychiatry; 2001 Jun; 62(6):413-20. PubMed ID: 11465517
[TBL] [Abstract][Full Text] [Related]
9. Care of depressed patients with anxiety symptoms.
Nutt DJ
J Clin Psychiatry; 1999; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
Amini H; Aghayan S; Jalili SA; Akhondzadeh S; Yahyazadeh O; Pakravan-Nejad M
J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
[TBL] [Abstract][Full Text] [Related]
11. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.
Szegedi A; Müller MJ; Anghelescu I; Klawe C; Kohnen R; Benkert O
J Clin Psychiatry; 2003 Apr; 64(4):413-20. PubMed ID: 12716243
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
[TBL] [Abstract][Full Text] [Related]
13. Mirtazapine versus fluoxetine in the treatment of panic disorder.
Ribeiro L; Busnello JV; Kauer-Sant'Anna M; Madruga M; Quevedo J; Busnello EA; Kapczinski F
Braz J Med Biol Res; 2001 Oct; 34(10):1303-7. PubMed ID: 11593305
[TBL] [Abstract][Full Text] [Related]
14. Does mirtazapine have a more rapid onset than SSRIs?
Quitkin FM; Taylor BP; Kremer C
J Clin Psychiatry; 2001 May; 62(5):358-61. PubMed ID: 11411818
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.
Costa e Silva J
J Clin Psychiatry; 1998 Jul; 59(7):352-7. PubMed ID: 9714263
[TBL] [Abstract][Full Text] [Related]
17. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
van Moffaert M; de Wilde J; Vereecken A; Dierick M; Evrard JL; Wilmotte J; Mendlewicz J
Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
Fawcett J; Barkin RL
J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
[TBL] [Abstract][Full Text] [Related]
20. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
Bennie EH; Mullin JM; Martindale JJ
J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
